Condition described as having 4 histopathologic types nodular sclerosis (50% of cases), lymphocyte predominance (best prognosis), mixed cellularity, and lymphocyte depletion; associated with Reed-Sternberg cells. Treatment is radiation (low-stage) and chemotherapy (high-stage) [Ann Arbor classification]; cure rate is 80%.